September 26, 2017 5:01 PM ET

Biotechnology

Company Overview of N8 Medical, LLC

Company Overview

N8 Medical, LLC, a biomedical technology company, develops a class of commercial compounds for medical device and pharmaceutical applications. The company focuses on creating medical devices and pharmaceuticals to combat a spectrum of infectious diseases and microbes. It develops ceragenin technology that comprise the formulations of ceragenins and cationic selective antimicrobials (CSA), which show bactericidal, fungicidal, and virucidal results against a variety of pathogens, including gram-positive and gram-negative bacteria, as well as multi-drug resistant strains of bacteria, such as Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. The company also provides LifeGu...

Columbus, OH 

United States

Phone:

877-686-3338

Key Executives for N8 Medical, LLC

Chief Executive Officer
Age: 64
Chief Financial Officer
Age: 63
Chief Technology Officer
Age: 65
Vice President of Development and General Counsel
Vice President of Licensing and Device Development
Compensation as of Fiscal Year 2017.

N8 Medical, LLC Key Developments

FDA Grants N8 Medical's Request for Breakthrough Device Designation for its CeraShield(TM) Endotracheal Tube

N8 Medical, LLC announced that the United States Food and Drug Administration (FDA) has approved the company's request to designate its CeraShield(TM) endotracheal tube as a "breakthrough device" pursuant to the recently-enacted 21st Century Cures Act. A "breakthrough device" is a device that may prevent or treat a life-threatening or irreversibly debilitating disease or condition. The N8 Medical CeraShield(TM) Endotracheal Tube is a specially-modified endotracheal tube that has been coated with a proprietary ceragenin compound formulation designed to prevent bacterial and fungal growth on the tube's surfaces. Patients who require mechanical ventilation in the ICU are intubated with endotracheal tubes to provide oxygen to the patient's lungs to assist with breathing. Within hours of intubation, bacteria and fungi may start to grow on the tube and form microbial aggregations known as biofilms. The CeraShield(TM) medical device coating technology is applicable to a broad range of medical devices commonly colonized with pathogenic bacteria and fungi, including devices for urology, vascular access, cardiology, orthopedics, and ear nose and throat (ENT), as well as other respiratory devices such as tracheostomy tubes. N8 Medical is working to pursue broad application of its CeraShield(TM) coating technology to create best-in-class antimicrobial medical devices designed to reduce the morbidity and, mortality and high costs and use of resources associated with hospital-acquired infections worldwide-both through independent commercialization efforts and through collaboration and partnering opportunities.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact N8 Medical, LLC, please visit www.n8medical.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.